Xiaodan Luo
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
- Renal Diseases and Glomerulopathies
Papers in
- Hematology 15
- Hematopoietic Stem Cell Transplantation 8
- Acute Myeloid Leukemia Research 7
-
- Hepatitis B Virus Studies 8
- Co-authors
- Huo Tan (11 shared papers)Haosheng Jin (1 shared paper)Zhixiang Jian (1 shared paper)Min Yu (1 shared paper)Baohua Hou (1 shared paper)Ye Lin (1 shared paper)Yu Zhou (1 shared paper)Yangqiu Li (6 shared papers)
- Journals
- Frontiers in Immunology (3 papers)Cancer Cell International (2 papers)Blood (1 paper)BMC Cancer (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- ChinaKenyaNew Zealand
In The Last Decade
Xiaodan Luo
43 papers receiving 801 citations
Xiaodan Luo's Hit Papers
Peers
Comparison fields: 5 of 76
- Hematology 385
- Nephrology 74
- Cancer Research 99
- Transplantation 13
- Medical Terminology 1
Countries citing papers authored by Xiaodan Luo
This map shows the geographic impact of Xiaodan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodan Luo more than expected).
Fields of papers citing papers by Xiaodan Luo
This network shows the impact of papers produced by Xiaodan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodan Luo. The network helps show where Xiaodan Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaodan Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial Hit paper breakdown → | 2020 | 258 |
| 2 | 2017 | 133 | |
| 3 | 2023 | 51 | |
| 4 | 2022 | 33 | |
| 5 | 2024 | 33 | |
| 6 | 2024 | 28 | |
| 7 | 2011 | 27 | |
| 8 | 2010 | 21 | |
| 9 | 2013 | 21 | |
| 10 | 2013 | 20 | |
| 11 | 2017 | 19 | |
| 12 | 2013 | 18 | |
| 13 | 2021 | 15 | |
| 14 | 2009 | 13 | |
| 15 | 2010 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2023 | 10 | |
| 18 | 2014 | 9 | |
| 19 | 2016 | 8 | |
| 20 | 2024 | 7 |
About Xiaodan Luo
Xiaodan Luo is a scholar working on Hematology, Epidemiology, Immunology, Nephrology and Pathology and Forensic Medicine, having authored 45 papers that have together received 822 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (8 papers), Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (7 papers), T-cell and B-cell Immunology (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Viral-associated cancers and disorders (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Hematology (385 citations), Nephrology (74 citations), Cancer Research (99 citations), Transplantation (13 citations) and Medical Terminology (1 citation). Xiaodan Luo has collaborated with scholars based in China, Kenya and New Zealand. Frequent co-authors include Huo Tan, Haosheng Jin, Zhixiang Jian, Min Yu, Baohua Hou, Ye Lin, Yu Zhou, Yangqiu Li, Jing Sun and Qifa Liu. Their work appears in journals such as Frontiers in Immunology, Cancer Cell International, Blood, BMC Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.